Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gamma-aminobutyric acid (GABA) A receptor alpha 5 subunit (GABRA5) is a subunit of the GABA(A) receptor, the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system. α5-containing GABA(A) receptors are predominantly found extrasynaptically in the hippocampus and contribute significantly to tonic inhibition. Activated by GABA, these receptors open their chloride channel pore, allowing Cl⁻ ions to flow into neurons, hyperpolarizing the cell membrane and reducing neuronal excitability. Altered function or expression of α5-containing GABA(A) receptors has been implicated in various neurological conditions, making it a target for nootropics and cognitive disorder therapies.
Allosteric modulation of chloride channel opening probability
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid A receptor alpha 5 subunit (GABRA5).